InGeneron

OverviewSuggest Edit

InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells. It focuses on patients who are impacted by musculoskeletal indications. The company produces a platform of medical devices that process adipose (body fat) tissue and isolate adipose-derived regenerative cells (ADRCs) to be reintroduced into the patient.
TypePrivate
Founded2006
HQHouston, TX, US
Websiteingeneron.com
Employee Ratings4.3

Latest Updates

Employees (est.) (Jul 2022)26(+4%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at InGeneron

David Mercer

David Mercer

Director of Engineering and Product Operations
Kent Lehr

Kent Lehr

Director
Fabian Alt

Fabian Alt

Chief Financial Officer
Christopher Alt

Christopher Alt

Director of Medical and Scientific Affairs
Amber Langner

Amber Langner

Director
Eckhard Alt

Eckhard Alt

Executive Chairman
Show more

InGeneron Office Locations

InGeneron has offices in Houston and München
Houston, TX, US (HQ)
8205 El Rio St
München, DE
24 Sonnenstraße
Show all (2)

InGeneron Financials and Metrics

Summary Metrics

Founding Date

2006

InGeneron total Funding

$47.5 m

InGeneron latest funding size

$23 m

Time since last funding

3 years ago

InGeneron investors

InGeneron's latest funding round in June 2019 was reported to be $23 m. In total, InGeneron has raised $47.5 m
Show all financial metrics

InGeneron Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

InGeneron Online and Social Media Presence

Embed Graph

InGeneron News and Updates

InGeneron Announces Publication of Rotator Cuff Feasibility Study

Results of a U.S. FDA-approved, randomized controlled feasibility study on treatment of symptomatic partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) are now available in the Journal of Orthopaedic Surgery and R…

InGeneron Announces Publication of Preclinical Results for its Cell Therapy in Chronic Ischemic Heart Failure

InGeneron, Inc., a regenerative medicine and cell therapy company, today announced the publication of promising results in developing a novel treatment for chronic ischemic heart failure using its regenerative cell therapy platform

InGeneron Extends Series D Financing to $43 Million to Bring Regenerative Cell Therapy into the Clinic

InGeneron, Inc., a clinical-stage regenerative medicine and cell therapy company, announced today the extension of its Series D financing by up to $23 million, totalling up to $43 million to be invested in the organization. The additional funds will come from InGeneron’s clinical partner Sanford Hea…

InGeneron Frequently Asked Questions

  • When was InGeneron founded?

    InGeneron was founded in 2006.

  • Who are InGeneron key executives?

    InGeneron's key executives are David Mercer, Kent Lehr and Fabian Alt.

  • How many employees does InGeneron have?

    InGeneron has 26 employees.

  • Who are InGeneron competitors?

    Competitors of InGeneron include Celling Biosciences, Regeneus and Sernova.

  • Where is InGeneron headquarters?

    InGeneron headquarters is located at 8205 El Rio St, Houston.

  • Where are InGeneron offices?

    InGeneron has offices in Houston and München.

  • How many offices does InGeneron have?

    InGeneron has 2 offices.